Mark J. De Graaf
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Glycoinformatic Profiling of Label-Free Intact Heparan Sulfate Oligosaccharides.
Journal: Molecular & cellular proteomics : MCP
Published: February 21, 2025
Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharides.
Journal: Molecular & cellular proteomics : MCP
Published: February 21, 2025
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis.
Journal: Frontiers in molecular biosciences
Published: May 16, 2023
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy.
Journal: Frontiers in pharmacology
Published: November 22, 2022
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Journal: Frontiers in immunology
Published: March 05, 2021
Increased Plasma Heparanase Activity in COVID-19 Patients.
Journal: Frontiers in immunology
Published: June 22, 2020
Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons.
Journal: Cell reports. Medicine
Published: June 16, 2020
RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues.
Journal: PloS one
Published: August 17, 2016
The identification of genetic pathways involved in vascular adaptations after physical deconditioning versus exercise training in humans.
Journal: Experimental physiology
Published: October 16, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026